Earth Science Tech, Inc. (ETST) Stock Price & Analysis
Earth Science Tech, Inc. (ETST) fell 4.00% to USD 0.12 as of July 25, 2026 at 15:05 UTC, according to Nexqual real-time market data.
ETST last closed at USD 0.13; the session ranged USD 0.12–0.12 on volume of 96,350 shares. Market capitalization is $34.58M, with a 52-week range of USD 0–0.24 (OID). Source: Nexqual, July 25, 2026 at 15:05 UTC.
Key Statistics (as of July 25, 2026 at 15:05 UTC)
| Price | USD 0.12 |
|---|---|
| Change | ▼ 4.00% (down) |
| Previous Close | USD 0.13 |
| Open | USD 0.12 |
| Day Range | USD 0.12 – 0.12 |
| 52-Week Range | USD 0 – 0.24 |
| Volume | 96,350 shares |
| Market Cap | $34.58M |
| Exchange | OID |
Technical Analysis (ETST)
Nexqual's technical model rates ETST "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 15:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.46 (neutral) |
| vs SMA50 | Below (USD 0.17) |
| MACD | -0.01 (negative) |
Analyst Ratings (ETST)
Wall Street analysts rate ETST "None" based on 1 analysts, with a mean price target of USD 1 (range USD 1–1), per Nexqual as of July 25, 2026 at 15:05 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 1 |
| High Target | USD 1 |
| Low Target | USD 1 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (ETST)
| Revenue Estimate | $9.97M |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0 vs est 0.01 ▼ miss |
| 2025-12-31 | USD 0 vs est 0.01 ▼ miss |
| 2025-09-30 | USD 0 vs est 0 ▲ beat |
| 2025-06-30 | USD 0 vs est 0 ▲ beat |
Source: Nexqual, July 25, 2026 at 15:05 UTC.
Financials & Fundamentals (ETST)
| Total Revenue | $35.70M |
|---|---|
| Revenue Growth (YoY) | +9.50% |
| Gross Margin | +71.40% |
| Operating Margin | +14.98% |
| Profit Margin | +10.17% |
| ROE | +66.12% |
| Debt / Equity | 1.37 |
| Current Ratio | 1.93 |
| Total Cash | $2.16M |
| Total Debt | $96,206 |
| Free Cash Flow | $659,723 |
Source: Nexqual, July 25, 2026 at 15:05 UTC.
Financial Health Score (ETST)
Nexqual rates Earth Science Tech, Inc.'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 15:05 UTC.
| Growth | Solid — Revenue +10% YoY (latest Q) |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — $2M cash, no debt |
| Cash Flow | Mixed — FCF $660K, slim 1.8% margin |
| Efficiency | Strong — ROE 66%, ROA 33.6% |
Ownership (ETST)
| Insider Ownership | +66.70% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 288.17M |
| Float | 89.26M |
Source: Nexqual, July 25, 2026 at 15:05 UTC.
Leadership (ETST)
Earth Science Tech, Inc. is led by Giorgio R. Saumat (age 45), Chairman & CEO, per Nexqual as of July 25, 2026 at 15:05 UTC.
| Chairman & CEO | Giorgio R. Saumat (age 45) |
|---|---|
| President, COO & Director | Mario G. Tabraue (age 45) |
| CFO & Director | Ernesto L. Flores (age 40) |
| Chief Technology Officer | Christopher Rose (age 48) |
| Treasurer, Secretary & Director | Victoria Losada (age 28) |
From Earth Science Tech, Inc.'s Latest SEC 10-K Filing (filed 2026-06-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Our approach focuses on high-conversion digital acquisition, strategic demographic targeting, and the utilization of proprietary technology to drive patient retention and brand loyalty across our diverse subsidiaries.
- The Company's principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment.
- Our ability to compete effectively is predicated on our unique vertical integration, which allows us to offer a value added healthcare experience.   Health and wellness   In the pharmaceutical compounding and telemedicine sectors the Company faces intense competition from both traditional brick-and-mortar pharmacies and a rapidly expanding cohort of digital health platforms.
- As we expand our geographical footprint, we continuously monitor state-level licensure requirements to ensure compliant dispensing across all active jurisdictions.   Telemedicine Regulation   The Company's digital health operations, facilitated through Peaks, DOC and our integrated pharmacy platforms, navigate a multifaceted landscape of federal and state laws.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CANL | CannLabs Inc. | USD 0 | ▲ 0% |
| NSPDF | NATURALLY SPLENDID ENTERPRISES | USD 0.04 | ▲ 0% |
| GBHPF | Global Hemp Group Inc | USD 0 | ▲ 0% |
| RSSFF | Affinor Growers, Inc. | USD 0.02 | ▲ 0% |
| GRWC | Grow Capital, Inc. | USD 0.07 | ▼ 70.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:05 UTC. This page is informational and not investment advice.